Ligand validation:4MPU

MES: 2-(N-MORPHOLINO)-ETHANESULFONIC ACID

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4MPU_MES_B_302	98%	30%	0.064	0.984	1.32	1.46	2	2	1	0	100%	1
4MPU_MES_A_301	52%	31%	0.168	0.927	1.44	1.29	2	2	0	0	100%	1
4MPX_MES_B_307	92%	2%	0.085	0.976	1.75	5.16	2	11	2	0	100%	1
4MPV_MES_B_302	81%	15%	0.121	0.975	2.11	1.65	1	3	1	0	100%	1
6P0P_MES_B_303	74%	14%	0.133	0.964	1.78	2.05	1	2	0	0	100%	1
2IUY_MES_B_1355	100%	9%	0.026	0.997	1.73	2.73	1	7	0	0	100%	1
3DPJ_MES_A_192	100%	8%	0.022	0.995	2.2	2.41	1	6	3	0	100%	1
8AJQ_MES_H_201	100%	38%	0.037	0.992	1.52	0.93	1	1	0	0	100%	1
4NWT_MES_L_301	100%	23%	0.045	0.99	1.24	1.94	2	4	0	0	100%	1
4S23_MES_B_502	100%	21%	0.05	0.993	1.97	1.34	1	1	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.